Global share markets weakened in October on the back of rising COVID-19 infections in the northern hemisphere.

Senator Biden is projected to win the US presidency, while President Trump’s chances hinge on successful legal challenges in multiple battleground states. Markets were buoyed in November by the successful trial of the Pfizer/BioNtech vaccine, which is expected to be approved by the FDA later in the month. Rising COVID-19 cases in Europe have forced…